The Growth Market's 2030 Cliff: why ~200 listed startups must cross JPY 10 bn

TL;DR - On 26 September 2025, TSE published proposed revisions to the Growth Market's continued-listing criteria. From 2030, the maintenance bar rises from "JPY 4 bn market cap after ten years" to "JPY 10 bn market cap after five years." - Approximately 200 Growth Market companies sit in the JPY 4–10 bn band today; ~70% of Growth listings sit below JPY 10 bn in total. The reform's design target is to make Growth listings institutionally investable by long-only managers who have largely shunned the segment for liquidity reasons. - Affected companies have three practical exit options: (1) M&A, (2) transfer to Standard (which has a JPY 1 bn tradable-share market-cap threshold), or (3) voluntary delisting. The five-year runway from announcement (Sept 2025) to enforcement (2030) is the longest of any reform in the post-2022 cycle.

Why the Growth Market needs its own reform

When the April 2022 restructuring consolidated Mothers and JASDAQ Growth into the new Growth Market, it inherited two long-standing structural problems. First, Growth-segment listings were small — the post-2022 continued-listing threshold sat at JPY 500 m tradable-share market cap, deliberately low to preserve access for early-stage issuers. Second, the segment had a "graduation problem": many companies that listed on Mothers in 2005-2015 never grew into adolescent-stage scale, and instead lingered for a decade or more at sub-JPY-10-bn market caps, neither growing nor delisting.

By end-2024 the Growth Market held ~610 listings, of which roughly 70% sat below JPY 10 bn in market cap — a population that, in regulatory framing, had effectively become "long-tail listed startups" rather than "high-growth companies on a graduation track." Institutional investors — particularly the long-only managers TSE wants to attract to Japan — had largely written the segment off as un-investable: positions large enough to matter for an institutional portfolio would require ownership stakes that distorted market dynamics or were impossible to liquidate.

The result was a vicious circle. Institutional investors avoided the segment, so trading volumes stayed low. Low trading volumes meant new issuers received weak post-IPO support. Weak post-IPO support meant companies struggled to grow into the next size tier. The segment had become a holding pen rather than a launchpad.

TSE's Follow-up Council had flagged this on its first list of priorities in January 2023 — "reviewing the Growth Market's effectiveness" — alongside the cost-of-capital request and the continuous English-disclosure push. The September 2025 proposal is the operational answer.

The September 2025 proposal

The proposed amendments, published in TSE's "Revision to the Growth Market's Continued Listing Criteria" on 26 September 2025, change the segment's central maintenance metric. Until 2030, the existing criteria continue to apply. From 2030, the new criteria take effect with a five-year clock running from listing date rather than ten years.

OLD vs NEW Growth-Market continued-listing criteria

The headline change is 2.5× higher bar, in half the time. A Growth-listed company under the old regime had a decade to grow into a JPY 4 bn market cap; under the new regime it has half that time to reach 2.5x the threshold.

Why JPY 10 bn, and why five years

The JPY 10 bn threshold is deliberately calibrated to align with the tradable-share market-cap floor for Prime (also JPY 10 bn). In other words, by year five of its public life, a Growth-Market issuer is expected to have reached a size equivalent — by free-float market cap — to a Prime-eligible company. The implicit policy statement is that Growth is no longer a permanent home for sub-scale public companies; it is a five-year incubator at the end of which the company should either be Prime-eligible by float, transferable to Standard, or out of the public market.

The five-year clock is similarly calibrated. The pre-2022 Mothers/JASDAQ-Growth regime had effectively a ten-year window before the maintenance test bit, and the policy view by 2024-2025 was that ten years was too generous: it allowed weak issuers to coast through the window without genuine progress. Five years aligns Japan with the typical VC-fund time horizon (US growth-IPO support windows are usually 5-7 years) and is short enough that under-performing companies must take action rather than wait out the clock.

The three exit options

Affected Growth Market companies — the ~200 currently in the JPY 4–10 bn band, plus a larger population at risk of failing the test by 2030 — have three structured exit options:

flowchart TD
    A["Growth Market company<br/>(end-2024 to 2030)"] --> B{"Year 5 post-IPO<br/>market cap projection<br/>vs JPY 10 bn"}
    B -->|"Achievable"| C["Maintain Growth listing<br/>(target ≥ JPY 10 bn by year 5)"]
    B -->|"Not achievable —<br/>strategic combination"| D["**Option 1: M&A**<br/>Acquired by strategic<br/>or PE buyer"]
    B -->|"Not achievable —<br/>capable of Standard"| E["**Option 2: Transfer to Standard**<br/>JPY 1 bn tradable-share<br/>market-cap threshold;<br/>≥ 25% tradable ratio;<br/>≥ 400 shareholders"]
    B -->|"Not achievable —<br/>private alternative"| F["**Option 3: Voluntary delisting**<br/>Sponsor-led MBO,<br/>founder-led take-private,<br/>or simple withdrawal"]

    classDef pass fill:#e6efe1,stroke:#3d6b3a,color:#1f3a1d
    classDef warn fill:#f9eecc,stroke:#a07e3a,color:#3a2d10
    classDef fail fill:#f4d5d0,stroke:#8a3f3a,color:#3a1614
    classDef decision fill:#f4f1ea,stroke:#7a6d4a,color:#3a3320
    class C pass
    class D,E warn
    class F fail
    class B decision

Option 1 — M&A

The cleanest exit is acquisition by a strategic acquirer or PE sponsor. The deal calendar for sub-scale Growth listings has thickened materially through 2024-2025, driven by three factors: rising domestic PE dry powder, foreign strategic buyers attracted by yen weakness and reasonable valuations, and the simple fact that ~200 companies looking for an exit on a five-year deadline produce a buyer's market. M&A as exit gives shareholders a control premium and resolves the listing constraint cleanly.

Option 2 — Transfer to Standard

A Growth-listed company that can reach the JPY 1 bn tradable-share market cap floor for Standard — combined with the 25% tradable-share ratio and ≥ 400 shareholders requirements — can voluntarily transfer down (or rather, sideways) to Standard. This option is most attractive for companies that have grown beyond the Growth segment's "high-growth/emerging" concept but have not reached Prime scale. Standard's continuous-listing obligations are lighter than Prime (no Prime-only CG Code supplementary principles), so the transfer is a tractable destination. By year-end 2025, several Growth-listed companies had already used this option pre-emptively.

Option 3 — Voluntary delisting

The third option is simply to leave the public market. This may take the form of a sponsor-led MBO, a founder-led take-private, or — for companies with limited acquirer interest and no clear next stage — a voluntary withdrawal after returning capital to shareholders. The 2023 METI Guidelines for Corporate Takeovers and the December 2024 MBO Guidelines for Listed Companies have made structured take-private transactions procedurally easier and reputationally more acceptable than they were a decade ago (Theme 5.4).

What the reform is really for

It is worth being clear about the policy logic. The proposed Growth Market revision is not a punishment of small companies. It is a deliberate redesign of the segment's role in the listing-segment ecosystem, and it serves three policy aims:

First, institutional-investability. The reform's stated goal is to make Growth listings attractive to long-only institutional managers. At current scales (median market cap below JPY 10 bn), institutional managers cannot take meaningful positions without moving the market or hitting position limits. Raising the average and median size of Growth-listed names — by removing the bottom of the distribution — improves institutional usability of the segment as a whole.

Second, IPO-pipeline quality. Companies considering an IPO will now look at a five-year, JPY 10 bn target rather than a ten-year, JPY 4 bn target. That higher bar should push IPOs toward more mature pre-listing development — more revenue scale at listing, stronger growth trajectories, and lower probability of the post-IPO lingering pattern that plagued Mothers/JASDAQ Growth. The unstated companion proposition is that some companies that would have IPO'd under the old rules will now stay private longer or pursue alternative liquidity (secondary M&A, PE-led recapitalisations), which TSE views as preferable to listing weak companies.

Third, the symmetry with Prime. The JPY 10 bn tradable-share-market-cap floor for Prime, the JPY 10 bn total-market-cap target for Growth by year five, and the JPY 1 bn tradable-share market-cap floor for Standard form a coherent three-tier scale: Growth aims for Prime-eligible size by year five; Standard is the home for sub-Prime-eligible companies; Prime is the genuine large-cap top tier. Symmetry of design makes the segment system easier to communicate to overseas investors — and makes segment migration a defined ladder rather than an ambiguous lateral move.

The 2025-2030 transition

A five-year runway from announcement (September 2025) to enforcement (2030) is the longest of any reform in the post-2022 cycle. That gives companies time to act, but it also means the regulatory pressure builds slowly. The likely chronology:

• 2026. Companies in the JPY 4–10 bn band publish first explicit strategic-alternatives reviews — internally, and (increasingly) to shareholders.
• 2027. First wave of M&A and take-private transactions among companies that conclude they cannot reach JPY 10 bn organically.
• 2028. Second wave of voluntary Standard-transfer applications from companies that have built a tradable-share base sufficient for Standard but cannot defend Growth's new bar.
• 2029. Pre-deadline acceleration: companies that have not yet acted under the previous waves face year-5 measurement dates, with the new rule's enforcement clock visible.
• 2030. Enforcement; failed companies enter the improvement-period regime (one year, six months for trading-volume tests), then delisting.

The total population effect is hard to predict precisely, but at the upper bound — if all ~200 companies in the JPY 4–10 bn band exit the segment over five years — the Growth Market could shrink to roughly 400-450 listings by the early 2030s, dominated by issuers either well above the new bar or on credible trajectories to clear it within five years of IPO.

What this means for Growth-Market IR

1. Map your year-5 market-cap trajectory now. If your company listed in or after 2025, your first JPY 10 bn measurement date is in or after 2030. Build an internal projection of market-cap evolution under base, upside, and stress cases, and present it to the board. The trajectory question is the most important one for Growth-listed companies in the next five years.

2. Treat strategic alternatives as part of the IR conversation. For companies in the JPY 4–10 bn band today, "what is the plan?" is now a legitimate question from any institutional investor. Be prepared to articulate which of the three exit paths — organic growth to JPY 10 bn, transfer to Standard, or M&A / take-private — is the working hypothesis, and what would trigger a pivot.

3. The Standard transfer is not failure. Several 2024-2025 Growth-to-Standard transfers were received well when management framed the move as a logical step at a particular stage of company maturity. The Standard segment's continued-listing obligations are lighter than Prime's, and the transfer preserves all the operational benefits of public-company status without the institutional-investability constraint.

4. For pre-IPO companies, the bar has moved. Any company considering a 2026-2027 Growth-Market IPO must underwrite to a 5-year, JPY 10 bn target. That likely means later-stage IPOs, larger offering sizes, and pre-IPO sponsor support stretched longer — all of which IR teams in pre-IPO companies should be discussing with their underwriters and existing investors.

5. The Prime/Standard/Growth ladder is now a coherent system. The September 2025 Growth revision completes the segment-system redesign that began with the April 2022 launch. Going forward, segment selection is a function of scale and trajectory — Growth for high-growth companies on a credible path to JPY 10 bn by year five; Standard for stable public companies with JPY 1 bn+ tradable float; Prime for global-dialogue large caps with JPY 10 bn+ tradable float. The ladder is finally legible.

Sources & further reading

• JPX, "Revision to the Growth Market's Continued Listing Criteria" (26 Sept 2025), https://www.jpx.co.jp/english/news/1020/20250926-01.html
• JPX, "Measures to Enhance the Functionality of the Growth Market," https://www.jpx.co.jp/english/equities/follow-up/03.html
• JPX, "Continued Listing Criteria (Growth Market)," https://www.jpx.co.jp/english/equities/listing/continue/outline/03.html
• JPX, "Market Segments," https://www.jpx.co.jp/english/equities/market-restructure/market-segments/index.html
• The Japan Times, "Companies delisted from TSE to hit record high in 2025" (30 Dec 2025), https://www.japantimes.co.jp/business/2025/12/30/markets/tse-2025-delisting-record/
• QUICK, "Tokyo Stock Exchange Continuing to Advance Reforms in 2025," https://corporate.quick.co.jp/en/japanmarketsview/equity/tokyo-stock-exchange-continuing-to-advance-reforms-in-2025-growing-expectations-for-changes-in-companies-and-markets/
• METI, "Guidelines for Corporate Takeovers" (2023), https://www.meti.go.jp/english/press/2023/0831_003.html
• METI, "Guidelines on Corporate Governance for Listed Subsidiaries / MBO," https://www.meti.go.jp/english/press/2019/0628_001.html

Cross-references

• Theme 3.1 — From Four Segments to Three. The April 2022 segment architecture into which the 2030 Growth revision fits.
• Theme 3.2 — The Tradable-Share Ratio. The continued-listing logic that the Growth-to-Standard transfer relies on.
• Theme 3.3 — The March 2025 Cliff. The procedural template (improvement period → watchlist → delisting) that the 2030 Growth regime will use.
• Theme 3.4 — TOPIX 2.0. The Phase 2 index reform that opens TOPIX inclusion to qualifying Growth and Standard issuers.
• Theme 5.4 — Hostile Is No Longer a Slur. The METI takeover guidelines that have made M&A and take-private exits more procedurally workable.
• Theme 5.3 — The Toyota Industries Deal Is the End of Keiretsu. The take-private pattern that has become a viable exit for sub-scale public companies.